Dasatinib Holiday for Improved Tolerability
NCT02890784
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
291
Enrollment
OTHER
Sponsor class
Conditions
Myeloid Leukemia, Chronic
Interventions
DRUG:
dasatinib (SPRYCEL®)
Sponsor
University of Jena